125 related articles for article (PubMed ID: 36449195)
1. Moderna, Pfizer-BioNTech, and Johnson & Johnson/Janssen Post-Covid Vaccine Hematological Adverse Events Including Cerebral Venous Sinus Thrombosis (CVST), Thrombotic Thrombocytopenia (VITT), Blood Clots, Increased Vaginal/Menstrual Bleeding and/or Miscarriage, Stillbirth Delivery, or Premature Birth.
Champigneulle O; Bennett CL
Cancer Treat Res; 2022; 184():151-160. PubMed ID: 36449195
[TBL] [Abstract][Full Text] [Related]
2. Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman.
Alhashim A; Hadhiah K; Al Khalifah Z; Alhaddad FM; Al ARhain SA; Bin Saif FH; Abid A; Al Gamdi O; Alsulaiman F; AlQarni M
Am J Case Rep; 2022 Feb; 23():e934744. PubMed ID: 35136010
[TBL] [Abstract][Full Text] [Related]
3. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
[TBL] [Abstract][Full Text] [Related]
4. Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021.
Shay DK; Gee J; Su JR; Myers TR; Marquez P; Liu R; Zhang B; Licata C; Clark TA; Shimabukuro TT
MMWR Morb Mortal Wkly Rep; 2021 May; 70(18):680-684. PubMed ID: 33956784
[TBL] [Abstract][Full Text] [Related]
5. Cerebral venous sinus thrombosis after adenovirus-vectored COVID-19 vaccination: review of the neurological-neuroradiological procedure.
Wittstock M; Walter U; Volmer E; Storch A; Weber MA; Großmann A
Neuroradiology; 2022 May; 64(5):865-874. PubMed ID: 35184205
[TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
[TBL] [Abstract][Full Text] [Related]
7. A probable case of vaccine-induced immune thrombotic thrombocytopenia secondary to Pfizer Comirnaty COVID-19 vaccine.
Goh Cy C; Teng Keat C; Su Kien C; Ai Sim G
J R Coll Physicians Edinb; 2022 Jun; 52(2):113-116. PubMed ID: 36146992
[TBL] [Abstract][Full Text] [Related]
8. Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries.
van de Munckhof A; Borhani-Haghighi A; Aaron S; Krzywicka K; van Kammen MS; Cordonnier C; Kleinig TJ; Field TS; Poli S; Lemmens R; Scutelnic A; Lindgren E; Duan J; Arslan Y; van Gorp EC; Kremer Hovinga JA; Günther A; Jood K; Tatlisumak T; Putaala J; Heldner MR; Arnold M; de Sousa DA; Wasay M; Arauz A; Conforto AB; Ferro JM; Coutinho JM;
Int J Stroke; 2023 Oct; 18(9):1112-1120. PubMed ID: 37277922
[TBL] [Abstract][Full Text] [Related]
9. Safety of COVID-19 vaccination in patients with previous cerebral venous sinus thrombosis.
Gil-Díaz A; Gil-Hernández A; Lozano-Jiménez AI; Benítez-Peña J; Conde-Martel A
Thromb Res; 2022 Jan; 209():84-85. PubMed ID: 34896915
[TBL] [Abstract][Full Text] [Related]
10. US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.
See I; Su JR; Lale A; Woo EJ; Guh AY; Shimabukuro TT; Streiff MB; Rao AK; Wheeler AP; Beavers SF; Durbin AP; Edwards K; Miller E; Harrington TA; Mba-Jonas A; Nair N; Nguyen DT; Talaat KR; Urrutia VC; Walker SC; Creech CB; Clark TA; DeStefano F; Broder KR
JAMA; 2021 Jun; 325(24):2448-2456. PubMed ID: 33929487
[TBL] [Abstract][Full Text] [Related]
11. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.
MacNeil JR; Su JR; Broder KR; Guh AY; Gargano JW; Wallace M; Hadler SC; Scobie HM; Blain AE; Moulia D; Daley MF; McNally VV; Romero JR; Talbot HK; Lee GM; Bell BP; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):651-656. PubMed ID: 33914723
[TBL] [Abstract][Full Text] [Related]
12. Case report: Vaccine-induced immune thrombotic thrombocytopenia complicated by acute cerebral venous thrombosis and hemorrhage after AstraZeneca vaccines followed by Moderna COVID-19 vaccine booster and surgery.
Chen QT; Liu Y; Chen YC; Chou CH; Lin YP; Lin YQ; Tsai MC; Chang BK; Ho TH; Lu CC; Sung YF
Front Neurol; 2022; 13():989730. PubMed ID: 36267879
[TBL] [Abstract][Full Text] [Related]
13. Thrombosis and Bleeding in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: A Systematic Review of Published Cases.
Clerici B; Pontisso E; Aloise C; Peroni B; Perricone R; Pisetta C; Scavone M; Birocchi S; Podda GM
Thromb Haemost; 2024 May; 124(5):423-431. PubMed ID: 38109906
[TBL] [Abstract][Full Text] [Related]
14. Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System.
Pawlowski C; Rincón-Hekking J; Awasthi S; Pandey V; Lenehan P; Venkatakrishnan AJ; Bade S; O'Horo JC; Virk A; Swift MD; Williams AW; Gores GJ; Badley AD; Halamka J; Soundararajan V
J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):105923. PubMed ID: 34627592
[TBL] [Abstract][Full Text] [Related]
15. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.
Krzywicka K; Heldner MR; Sánchez van Kammen M; van Haaps T; Hiltunen S; Silvis SM; Levi M; Kremer Hovinga JA; Jood K; Lindgren E; Tatlisumak T; Putaala J; Aguiar de Sousa D; Middeldorp S; Arnold M; Coutinho JM; Ferro JM
Eur J Neurol; 2021 Nov; 28(11):3656-3662. PubMed ID: 34293217
[TBL] [Abstract][Full Text] [Related]
16. Decompressive surgery in cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia.
Krzywicka K; Aguiar de Sousa D; Cordonnier C; Bode FJ; Field TS; Michalski D; Pelz J; Skjelland M; Wiedmann M; Zimmermann J; Wittstock M; Zanotti B; Ciccone A; Bandettini di Poggio M; Borhani-Haghighi A; Chatterton S; Aujayeb A; Devroye A; Dizonno V; Geeraerts T; Giammello F; Günther A; Ichaporia NR; Kleinig T; Kristoffersen ES; Lemmens R; De Maistre E; Mirzaasgari Z; Payen JF; Putaala J; Petruzzellis M; Raposo N; Sadeghi-Hokmabadi E; Schoenenberger S; Umaiorubahan M; Sylaja PN; van de Munckhof A; Sánchez van Kammen M; Lindgren E; Jood K; Scutelnic A; Heldner MR; Poli S; Kruip MJHA; Arauz A; Conforto AB; Aaron S; Middeldorp S; Tatlisumak T; Arnold M; Coutinho JM; Ferro JM;
Eur J Neurol; 2023 May; 30(5):1335-1345. PubMed ID: 36773014
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
Self WH; Tenforde MW; Rhoads JP; Gaglani M; Ginde AA; Douin DJ; Olson SM; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T; Ghamande S; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Lindsell CJ; Hart KW; Zhu Y; Mills L; Lester SN; Stumpf MM; Naioti EA; Kobayashi M; Verani JR; Thornburg NJ; Patel MM;
MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1337-1343. PubMed ID: 34555004
[TBL] [Abstract][Full Text] [Related]
18. Endovascular treatment of cerebral sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia.
Weller J; Krzywicka K; van de Munckhof A; Dorn F; Althaus K; Bode FJ; Bandettini di Poggio M; Buck B; Kleinig T; Cordonnier C; Dizonno V; Duan J; Elkady A; Chew BLA; Garcia-Esperon C; Field TS; Legault C; Morin Martin M; Michalski D; Pelz J; Schoenenberger S; Nagel S; Petruzzellis M; Raposo N; Skjelland M; Zimatore DS; Aaron S; Sanchez van Kammen M; Aguiar de Sousa D; Lindgren E; Jood K; Scutelnic A; Heldner MR; Poli S; Arauz A; Conforto AB; Putaala J; Tatlisumak T; Arnold M; Coutinho JM; Günther A; Zimmermann J; Ferro JM
Eur Stroke J; 2024 Mar; 9(1):105-113. PubMed ID: 37771138
[TBL] [Abstract][Full Text] [Related]
19. A COVID-Positive 52-Year-Old Man Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccination: A Case-Study.
Shazley O; Alshazley M
Cureus; 2021 Jul; 13(7):e16383. PubMed ID: 34408937
[TBL] [Abstract][Full Text] [Related]
20. Outcomes After Decompressive Surgery for Severe Cerebral Venous Sinus Thrombosis Associated or Not Associated with Vaccine-Induced Immune Thrombosis with Thrombocytopenia: A Multicenter Cohort Study.
Pelz JO; Kenda M; Alonso A; Etminan N; Wittstock M; Niesen WD; Lambeck J; Güresir E; Wach J; Lampmannn T; Dziewas R; Wiedmann M; Schneider H; Bayas A; Christ M; Mengel A; Poli S; Brämer D; Lindner D; Pfrepper C; Roth C; Salih F; Günther A; Michalski D;
Neurocrit Care; 2024 Apr; 40(2):621-632. PubMed ID: 37498459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
